Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
30% glucose solution is a concentrated carbohydrate solution utilized as a non-pharmacological analgesic intervention for procedural pain in neonates. In a clinical trial conducted by Region Örebro County at Örebro University Hospital, the solution was evaluated for its efficacy in reducing pain during routine neonatal hip examinations. The mechanism of action involves the stimulation of sweet taste receptors (TAS1R2 and TAS1R3) on the tongue, which activates the endogenous opioid system, leading to a reduction in crying time and pain scores. It is typically administered orally in small volumes (e.g., 2 ml) shortly before a painful procedure. This intervention is widely used in neonatal care as a safe and effective method for managing minor procedural distress.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 30% glucose solution.